Ansari Farzaneh, Neshasteh-Riz Ali, Paydar Reza, Mohagheghi Fathollah, Felegari Sahar, Beigi Manijeh, Cheraghi Susan
Department of Radiation Sciences, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.
Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran.
J Med Signals Sens. 2025 May 1;15:14. doi: 10.4103/jmss.jmss_51_24. eCollection 2025.
This study aimed to evaluate the effectiveness of clinical, dosimetric, and radiomic features from computed tomography (CT) scans in predicting the probability of heart failure in breast cancer patients undergoing chemoradiation treatment.
We selected 54 breast cancer patients who received left-sided chemoradiation therapy and had a low risk of natural heart failure according to the Framingham score. We compared echocardiographic patterns and ejection fraction (EF) measurements before and 3 years after radiotherapy for each patient. Based on these comparisons, we evaluated the incidence of heart failure 3 years postchemoradiation therapy. For machine learning (ML) modeling, we first segmented the heart as the region of interest in CT images using a deep learning technique. We then extracted radiomic features from this region. We employed three widely used classifiers - decision tree, K-nearest neighbor, and random forest (RF) - using a combination of radiomic, dosimetric, and clinical features to predict chemoradiation-induced heart failure. The evaluation criteria included accuracy, sensitivity, specificity, and the area under the receiver operating characteristic curve (area under the curve [AUC]).
In this study, 46% of the patients experienced heart failure, as indicated by EF. A total of 873 radiomic features were extracted from the segmented area. Out of 890 combined radiomic, dosimetric, and clinical features, 15 were selected. The RF model demonstrated the best performance, with an accuracy of 0.85 and an AUC of 0.98. Patient age and V5 irradiated heart volume were identified as key predictors of chemoradiation-induced heart failure.
Our quantitative findings indicate that employing ML methods and combining radiomic, dosimetric, and clinical features to identify breast cancer patients at risk of cardiotoxicity is feasible.
本研究旨在评估计算机断层扫描(CT)图像的临床、剂量学和影像组学特征在预测接受放化疗的乳腺癌患者发生心力衰竭可能性方面的有效性。
我们选取了54例接受左侧放化疗且根据弗明汉评分自然发生心力衰竭风险较低的乳腺癌患者。我们比较了每位患者放疗前及放疗后3年的超声心动图模式和射血分数(EF)测量值。基于这些比较,我们评估了放化疗后3年心力衰竭的发生率。对于机器学习(ML)建模,我们首先使用深度学习技术将心脏分割为CT图像中的感兴趣区域。然后我们从该区域提取影像组学特征。我们采用了三种广泛使用的分类器——决策树、K近邻和随机森林(RF)——结合影像组学、剂量学和临床特征来预测放化疗引起的心力衰竭。评估标准包括准确率、灵敏度、特异度以及受试者工作特征曲线下面积(曲线下面积[AUC])。
在本研究中,46%的患者出现了EF所示的心力衰竭。从分割区域共提取了873个影像组学特征。在890个综合的影像组学、剂量学和临床特征中,选取了15个。RF模型表现最佳,准确率为0.85,AUC为0.98。患者年龄和受照射心脏的V5体积被确定为放化疗引起心力衰竭的关键预测因素。
我们的定量研究结果表明,采用ML方法并结合影像组学、剂量学和临床特征来识别有心脏毒性风险的乳腺癌患者是可行的。